AI
Saturday, March 29, 2025 10:12:45 PM
Gus,
The development of a subcutaneous version is interesting news and highlights the blockbuster status of the drug and the expanding checkpoint inhibitor drug class that it represents!
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-plans-us-launch-subcutaneous-version-keytruda-october-1-2025-03-27/
Any news about pembrolizumab reminds us of NWBO since DCVax-L is currently being studied in combo with pembrolizumab (and the Roswell DC platform is also involved in combo trials with pembrolizumab). The UCLA combo might be the most relevant today since DCVax-L has a completed P3 and we are awaiting the MAA decision—combos will be the next most intriguing topic to consider after news about the MHRA decision is announced!
https://www.clinicaltrials.gov/study/NCT04201873
https://robertprinslab.healthsciences.ucla.edu/research
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175992462
The development of a subcutaneous version is interesting news and highlights the blockbuster status of the drug and the expanding checkpoint inhibitor drug class that it represents!
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-plans-us-launch-subcutaneous-version-keytruda-october-1-2025-03-27/
Any news about pembrolizumab reminds us of NWBO since DCVax-L is currently being studied in combo with pembrolizumab (and the Roswell DC platform is also involved in combo trials with pembrolizumab). The UCLA combo might be the most relevant today since DCVax-L has a completed P3 and we are awaiting the MAA decision—combos will be the next most intriguing topic to consider after news about the MHRA decision is announced!
https://www.clinicaltrials.gov/study/NCT04201873
https://robertprinslab.healthsciences.ucla.edu/research
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175992462
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
